Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus
Open Access
- 1 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 180 (3) , P1-P22
Abstract
Purpose: To provide practice recommendations for the diagnosis and management of hypoparathyroidism in adults. Methods: Key questions pertaining to the diagnosis and management of hypoparathyroidism were addressed following a literature review. We searched PubMed, MEDLINE, EMBASE and Cochrane databases from January 2000 to March 2018 using keywords ‘hypoparathyroidism, diagnosis, treatment, calcium, PTH, calcidiol, calcitriol, hydrochlorothiazide and pregnancy’. Only English language papers involving humans were included. We excluded letters, reviews and editorials. The quality of evidence was evaluated based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. These standards of care for hypoparathyroidism have been endorsed by the Canadian Society of Endocrinology and Metabolism. Results: Hypoparathyroidism is a rare disease characterized by hypocalcemia, hyperphosphatemia and a low or inappropriately normal serum parathyroid hormone level (PTH). The majority of cases are post-surgical (75%) with nonsurgical causes accounting for the remaining 25% of cases. A careful review is required to determine the etiology of the hypoparathyroidism in individuals with nonsurgical disease. Hypoparathyroidism is associated with significant morbidity and poor quality of life. Treatment requires close monitoring as well as patient education. Conventional therapy with calcium supplements and active vitamin D analogs is effective in improving serum calcium as well as in controlling the symptoms of hypocalcemia. PTH replacement is of value in lowering the doses of calcium and active vitamin D analogs required and may be of value in lowering long-term complications of hypoparathyroidism. This manuscript addresses acute and chronic management of hypoparathyroidism in adults. Main conclusions: Hypoparathyroidism requires careful evaluation and pharmacologic intervention in order to improve serum calcium and control the symptoms of hypocalcemia. Frequent laboratory monitoring of the biochemical profile and patient education is essential to achieving optimal control of serum calcium.Keywords
This publication has 100 references indexed in Scilit:
- Long-Term Treatment of 12 Children with Chronic Hypoparathyroidism: A Randomized Trial Comparing Synthetic Human Parathyroid Hormone 1-34 versus Calcitriol and CalciumThe Journal of Clinical Endocrinology & Metabolism, 2010
- Lactation and Bone Turnover: A Conundrum of Marked Bone Loss in the Setting of Coupled Bone TurnoverThe Journal of Clinical Endocrinology & Metabolism, 2010
- Vitamin D2 Is as Effective as Vitamin D3 in Maintaining Circulating Concentrations of 25-Hydroxyvitamin DThe Journal of Clinical Endocrinology & Metabolism, 2008
- CLDN16 Genotype Predicts Renal Decline in Familial Hypomagnesemia with Hypercalciuria and NephrocalcinosisJournal of the American Society of Nephrology, 2008
- Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemiaJournal of Clinical Investigation, 2007
- Hypoparathyroidism in mitochondrial trifunctional protein deficiencyThe Journal of Pediatrics, 1996
- Calcium homeostasis in normal pregnancy and puerperium: A longitudinal studyActa Obstetricia et Gynecologica Scandinavica, 1994
- Abnormalities in G protein-coupled signal transduction pathways in human disease.Journal of Clinical Investigation, 1993
- Hypoparathyroidism in Wilson's DiseaseNew England Journal of Medicine, 1983
- Treatment of Hypoparathyroid Patients with ChlorthalidoneNew England Journal of Medicine, 1978